IntegenX Acquires DNA Consumable Portfolio From GE Healthcare


PLEASANTON, Calif., Apr 23, 2012 (BUSINESS WIRE) — IntegenX Inc., a privately held company that is a leader in the emerging field of rapid human DNA identification, today announced that it has acquired SV Corp, a wholly owned subsidiary of GE Healthcare Bio-Sciences. IntegenX will leverage SV Corp’s products and intellectual property assets to expand its consumables offering and to accelerate the commercialization of its RapidHIT(TM) 200 Human DNA Identification System. GE Healthcare Bio-Sciences is a subsidiary of GE Healthcare. Financial terms of the agreement were not disclosed.